Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62,500,000
-
Number of holders
-
318
-
Total 13F shares, excl. options
-
64,715,729
-
Shares change
-
-2,087,007
-
Total reported value, excl. options
-
$5,987,635,020
-
Value change
-
-$229,310,672
-
Put/Call ratio
-
52%
-
Number of buys
-
190
-
Number of sells
-
123
-
Price
-
$92.50
Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q3 2024
As of 30 Sep 2024 Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) had 392 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 64,715,729 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, MACQUARIE GROUP LTD, and JPMORGAN CHASE & CO.
This table shows 392 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.